
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7136500
[patent_doc_number] => 20040044077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Agents for inhibiting or restoring skin damage caused by drying and method for evaluating the same'
[patent_app_type] => new
[patent_app_number] => 10/465912
[patent_app_country] => US
[patent_app_date] => 2003-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8678
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20040044077.pdf
[firstpage_image] =>[orig_patent_app_number] => 10465912
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/465912 | Agents for inhibiting or restoring skin damage caused by drying and method for evaluating the same | Jun 26, 2003 | Abandoned |
Array
(
[id] => 7428087
[patent_doc_number] => 20040265949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Method and building blocks for preparing C-terminally labelled peptides'
[patent_app_type] => new
[patent_app_number] => 10/607175
[patent_app_country] => US
[patent_app_date] => 2003-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9167
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265949.pdf
[firstpage_image] =>[orig_patent_app_number] => 10607175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/607175 | Method and building blocks for preparing C-terminally labelled peptides | Jun 25, 2003 | Abandoned |
Array
(
[id] => 443142
[patent_doc_number] => 07256216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-14
[patent_title] => 'Liquid pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/602215
[patent_app_country] => US
[patent_app_date] => 2003-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3808
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/256/07256216.pdf
[firstpage_image] =>[orig_patent_app_number] => 10602215
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/602215 | Liquid pharmaceutical compositions | Jun 23, 2003 | Issued |
Array
(
[id] => 7270463
[patent_doc_number] => 20040058981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer'
[patent_app_type] => new
[patent_app_number] => 10/457079
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4807
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058981.pdf
[firstpage_image] =>[orig_patent_app_number] => 10457079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/457079 | Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer | Jun 5, 2003 | Abandoned |
Array
(
[id] => 6809578
[patent_doc_number] => 20030199517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Use of phosphordiesterase inhibitors in the treatment of prostatic diseases'
[patent_app_type] => new
[patent_app_number] => 10/443870
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2694
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199517.pdf
[firstpage_image] =>[orig_patent_app_number] => 10443870
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/443870 | Use of phosphodiesterase inhibitors in the treatment of prostatic diseases | May 22, 2003 | Issued |
Array
(
[id] => 6678129
[patent_doc_number] => 20030228269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Use of stilbene derivatives for dandruff treatment'
[patent_app_type] => new
[patent_app_number] => 10/296726
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1629
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228269.pdf
[firstpage_image] =>[orig_patent_app_number] => 10296726
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/296726 | Use of stilbene derivatives for dandruff treatment | May 15, 2003 | Abandoned |
Array
(
[id] => 6983940
[patent_doc_number] => 20050154010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogs'
[patent_app_type] => utility
[patent_app_number] => 10/509693
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6875
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20050154010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509693
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509693 | Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogs | May 15, 2003 | Abandoned |
Array
(
[id] => 4518
[patent_doc_number] => 07816403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-19
[patent_title] => 'Method of inhibiting ATF/CREB and cancer cell growth and pharmaceutical compositions for same'
[patent_app_type] => utility
[patent_app_number] => 10/437477
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 23
[patent_no_of_words] => 12308
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/816/07816403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10437477
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/437477 | Method of inhibiting ATF/CREB and cancer cell growth and pharmaceutical compositions for same | May 13, 2003 | Issued |
Array
(
[id] => 7256339
[patent_doc_number] => 20050143346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Composition for treating cancer containing n,n-dimethylphytosphingosine'
[patent_app_type] => utility
[patent_app_number] => 10/512126
[patent_app_country] => US
[patent_app_date] => 2003-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6802
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143346.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512126
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512126 | Composition for treating cancer containing n,n-dimethylphytosphingosine | Apr 30, 2003 | Abandoned |
Array
(
[id] => 6640108
[patent_doc_number] => 20030212088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Methods and compositions for treating, preventing or delaying onset of a neoplasm'
[patent_app_type] => new
[patent_app_number] => 10/423761
[patent_app_country] => US
[patent_app_date] => 2003-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5733
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212088.pdf
[firstpage_image] =>[orig_patent_app_number] => 10423761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/423761 | Methods and compositions for treating, preventing or delaying onset of a neoplasm | Apr 24, 2003 | Abandoned |
Array
(
[id] => 7437385
[patent_doc_number] => 20040002536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Composition of melatonin for induction of general anesthesia'
[patent_app_type] => new
[patent_app_number] => 10/420243
[patent_app_country] => US
[patent_app_date] => 2003-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3024
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002536.pdf
[firstpage_image] =>[orig_patent_app_number] => 10420243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/420243 | Composition of melatonin for induction of general anesthesia | Apr 21, 2003 | Abandoned |
Array
(
[id] => 7297279
[patent_doc_number] => 20040214798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Nitroaryl phosphoramide compositions and methods for targeting and inhibiting undesirable cell growth or proliferation'
[patent_app_type] => new
[patent_app_number] => 10/421000
[patent_app_country] => US
[patent_app_date] => 2003-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19677
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10421000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/421000 | Nitroaryl phosphoramide compositions and methods for targeting and inhibiting undesirable cell growth or proliferation | Apr 21, 2003 | Abandoned |
Array
(
[id] => 22582
[patent_doc_number] => 07799826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-21
[patent_title] => 'Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation'
[patent_app_type] => utility
[patent_app_number] => 10/418513
[patent_app_country] => US
[patent_app_date] => 2003-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14548
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/799/07799826.pdf
[firstpage_image] =>[orig_patent_app_number] => 10418513
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/418513 | Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation | Apr 15, 2003 | Issued |
Array
(
[id] => 7225890
[patent_doc_number] => 20040072889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia'
[patent_app_type] => new
[patent_app_number] => 10/414867
[patent_app_country] => US
[patent_app_date] => 2003-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45261
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072889.pdf
[firstpage_image] =>[orig_patent_app_number] => 10414867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/414867 | Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia | Apr 15, 2003 | Abandoned |
Array
(
[id] => 232853
[patent_doc_number] => 07598278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-06
[patent_title] => 'Administration of pyridinedicarboxylic acid compounds for stimulating or inducing the growth of human keratinous fibers and/or arresting their loss'
[patent_app_type] => utility
[patent_app_number] => 10/410402
[patent_app_country] => US
[patent_app_date] => 2003-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6300
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/598/07598278.pdf
[firstpage_image] =>[orig_patent_app_number] => 10410402
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/410402 | Administration of pyridinedicarboxylic acid compounds for stimulating or inducing the growth of human keratinous fibers and/or arresting their loss | Apr 9, 2003 | Issued |
Array
(
[id] => 7190799
[patent_doc_number] => 20040204435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Alternating treatment with topoisomerase I and topoisomerase II inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/410627
[patent_app_country] => US
[patent_app_date] => 2003-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7249
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204435.pdf
[firstpage_image] =>[orig_patent_app_number] => 10410627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/410627 | Alternating treatment with topoisomerase I and topoisomerase II inhibitors | Apr 8, 2003 | Abandoned |
Array
(
[id] => 6912982
[patent_doc_number] => 20050176740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/510542
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 36478
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176740.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510542
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510542 | Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor | Apr 7, 2003 | Abandoned |
Array
(
[id] => 6978536
[patent_doc_number] => 20050288254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Novel therapeutical use of agonist ligands specific to g2a receptor'
[patent_app_type] => utility
[patent_app_number] => 10/509300
[patent_app_country] => US
[patent_app_date] => 2003-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8819
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20050288254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509300
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509300 | Therapeutic use of agonist ligands specific to G2A receptor | Mar 24, 2003 | Issued |
Array
(
[id] => 6835204
[patent_doc_number] => 20030162750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Lyophilizate of lipid complex of water insoluble porphyrins'
[patent_app_type] => new
[patent_app_number] => 10/394536
[patent_app_country] => US
[patent_app_date] => 2003-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4034
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162750.pdf
[firstpage_image] =>[orig_patent_app_number] => 10394536
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/394536 | Lyophilizate of lipid complex of water insoluble porphyrins | Mar 20, 2003 | Abandoned |
Array
(
[id] => 6874856
[patent_doc_number] => 20030195153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Methods and kits for treating and diagnosing leiomyomas'
[patent_app_type] => new
[patent_app_number] => 10/389866
[patent_app_country] => US
[patent_app_date] => 2003-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11536
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20030195153.pdf
[firstpage_image] =>[orig_patent_app_number] => 10389866
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/389866 | Methods and kits for treating and diagnosing leiomyomas | Mar 16, 2003 | Abandoned |